#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14886	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2086	704.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	881	C,A	853,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14886	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2086	704.0	0	HET	.	.	.	C207T,G	.	207	207	C	441	441	C	845	C,T,G	626,181,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	830	C,T	801,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1985	1985	G	826	G,A	612,196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	820	C,T	798,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	873	A,G	855,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	795	C	775	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27174	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3619	745.2	0	HET	.	.	.	C738T	.	738	738	C	1085	1085	C	819	C,T	630,178	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	18	blaTEM	861	194	100.0	blaTEM.l15.c4.ctg.1	194	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2076	folP	855	855	100.0	folP.l6.c4.ctg.1	1537	134.1	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	190;190;189	A;G;C	183;183;181	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3591	156.2	1	SNP	p	S91F	1	.	.	271	273	TTC	627	629	TTC	190;189;188	T;T;C	188;186;187	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3591	156.2	1	SNP	p	D95G	1	.	.	283	285	GGC	639	641	GGC	173;170;169	G;G;C	171;168;166	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3591	156.2	1	SNP	p	G95N	0	.	.	283	285	GGC	639	641	GGC	173;170;169	G;G;C	171;168;166	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1638	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1227	132.2	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	216;215;215	G;G;C	207;206;205	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	866	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	938	90.9	0	.	n	.	0	A197.	DEL	197	197	A	504	504	A	190	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4948	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	160.4	1	SNP	p	D86N	0	.	.	256	258	GAC	639	641	GAC	198;196;202	G;A;C	192;178;197	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4948	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	160.4	1	SNP	p	R87W	0	.	.	259	261	CGT	642	644	CGT	203;204;206	C;G,C;T	199;195,1;193	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4948	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	160.4	1	SNP	p	R87I	0	.	.	259	261	CGT	642	644	CGT	203;204;206	C;G,C;T	199;195,1;193	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4948	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	160.4	1	SNP	p	S87R	1	.	.	259	261	CGT	642	644	CGT	203;204;206	C;G,C;T	199;195,1;193	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4948	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3059	160.4	1	SNP	p	S88P	0	.	.	262	264	TCC	645	647	TCC	206;205;205	T;C;C,G	199;197;199,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4204	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2597	160.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1511	1513	GGC	190;189;189	G;G,A;C	186;184,1;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1228	1230	GCC	224;225;222	G;C,T;C	217;218,1;214	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1231	1233	ATG	223;222;223	A;T;G,A	217;215;214,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1243	1245	ACC	224;227;225	A;C;C	212;218;218	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1243	1245	ACC	224;227;225	A;C;C	212;218;218	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1744	1746	ACC	195;192;190	A;C;C	185;189;185	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1798	1800	GCG	193;196;199	G;C;G	189;189;195	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1798	1800	GCG	193;196;199	G;C;G	189;189;195	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1921	1923	GGT	143;144;144	G;G;T	139;140;137	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1930	1932	AGC	140;141;138	A;G;C,T	135;140;134,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4018	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2367	168.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1948	1950	CCG	128;129;127	C,G;C;G,C	112,2;118;109,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5672	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3049	184.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1603	1605	CCG	179;182;182	C,G;C;G	164,2;176;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2312	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1894	120.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	597	597	C	174	C,G	168,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2698	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1756	151.8	1	SNP	p	G120K	1	.	.	358	360	AAG	650	652	AAG	210;210;211	A,C;A,G;G	199,1;204,1;197	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2698	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1756	151.8	1	SNP	p	N121D	0	.	.	361	363	AAC	653	655	AAC	214;214;211	A;A;C,A	209;207;200,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2698	porB1b	1038	1038	100.0	porB1b.l6.c30.ctg.1	1756	151.8	1	SNP	p	A121N	1	.	.	361	363	AAC	653	655	AAC	214;214;211	A;A;C,A	209;207;200,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9800	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4827	201.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1104	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1103	99.0	1	SNP	p	V57M	1	.	.	169	171	ATG	555	557	ATG	215;213;213	A;T;G	208;206;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
